{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:57:13Z","timestamp":1791262633016,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05008-x","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:29:13Z","timestamp":1749054553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Radiosensitizing effects of Withaferin A in gastric cancer cells via autophagy Inhibition and mitochondrial disruption"],"prefix":"10.1038","volume":"15","author":[{"given":"Ping","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemeng","family":"JI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"5008_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina, M., Arrazubi, V., Diez, M. & Tabernero, J. Current developments in gastric cancer: From molecular profiling to treatment strategy. Nat. Rev. Gastroenterol. Hepatol. 20, 155\u2013170 (2023).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"5008_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan, W. L., He, Y. & Xu, R. H. Gastric cancer treatment: Recent progress and future perspectives. J. Hematol. Oncol. 16, 57 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"5008_CR3","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.3390\/nu16132141","volume":"16","author":"D Trautmann","year":"2024","unstructured":"Trautmann, D., Suazo, F., Torres, K. & Sim\u00f3n, L. Antitumor effects of resveratrol opposing mechanisms of helicobacter pylori in gastric cancer. Nutrients 16, 2141 (2024).","journal-title":"Nutrients"},{"key":"5008_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/ph16020160","volume":"16","author":"S Kumar","year":"2023","unstructured":"Kumar, S. et al. Withaferin A: A pleiotropic anticancer agent from the Indian medicinal plant Withania somnifera (L.) Dunal. Pharmaceuticals 16, 160 (2023).","journal-title":"Pharmaceuticals"},{"key":"5008_CR5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/mc.23545","volume":"62","author":"ER Hahm","year":"2023","unstructured":"Hahm, E. R., Kim, S. H. & Singh, S. V. Withaferin A inhibits breast cancer-induced osteoclast differentiation. Mol. Carcinog. 62, 1051\u20131061 (2023).","journal-title":"Mol. Carcinog."},{"key":"5008_CR6","doi-asserted-by":"crossref","unstructured":"Pal, D. et al. Withaferin A: The potent anti-cancer agent from Ashwagandha. Minerva Biotechnol. Biomol. Res. 36 (2024).","DOI":"10.23736\/S2724-542X.24.03124-9"},{"key":"5008_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/1566524023666230418094708","volume":"24","author":"P Abeesh","year":"2024","unstructured":"Abeesh, P. & Guruvayoorappan, C. The therapeutic effects of Withaferin A against cancer: Overview and updates. Curr. Mol. Med. 24, 404\u2013418 (2024).","journal-title":"Curr. Mol. Med."},{"key":"5008_CR8","doi-asserted-by":"publisher","first-page":"116389","DOI":"10.1016\/j.taap.2023.116389","volume":"461","author":"R Checker","year":"2023","unstructured":"Checker, R. et al. Withaferin A, a steroidal lactone, selectively protects normal lymphocytes against ionizing radiation induced apoptosis and genotoxicity via activation of ERK\/Nrf-2\/HO-1 axis. Toxicol. Appl. Pharmcol. 461, 116389 (2023).","journal-title":"Toxicol. Appl. Pharmcol."},{"key":"5008_CR9","doi-asserted-by":"crossref","unstructured":"Abeesh, P., Guruvayoorappan, C., Withaferin, A-E. & PEGylated Nanoliposomes induce apoptosis in B16F10 melanoma cells by regulating Bcl2 and Bcl Xl genes and mitigates murine solid tumor development. J. Environ. Pathol. Toxicol. Oncol. 43 (2024).","DOI":"10.1615\/JEnvironPatholToxicolOncol.2023046909"},{"key":"5008_CR10","doi-asserted-by":"crossref","unstructured":"Zhu, H. et al. Withaferin a modulation of microglia autophagy mitigates neuroinflammation and enhances cognitive function in POCD. (2023).","DOI":"10.21203\/rs.3.rs-3508591\/v1"},{"key":"5008_CR11","doi-asserted-by":"publisher","first-page":"155317","DOI":"10.1016\/j.phymed.2023.155317","volume":"128","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of Sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells. Phytomedicine 128, 155317 (2024).","journal-title":"Phytomedicine"},{"key":"5008_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/27697061.2023.2228863","volume":"43","author":"P Kumar","year":"2024","unstructured":"Kumar, P. et al. Revisiting the multifaceted therapeutic potential of Withaferin A (WA), a novel steroidal lactone, W-ferinAmax ashwagandha, from Withania Somnifera (L) Dunal. J. Am. Nutr. Assoc. 43, 115\u2013130 (2024).","journal-title":"J. Am. Nutr. Association"},{"key":"5008_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2174\/0115680096262915231026050602","volume":"24","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Withaferin A inhibits liver cancer tumorigenesis by suppressing aerobic glycolysis through the p53\/IDH1\/HIF-1\u03b1 signaling Axis. Curr. Cancer Drug. Targets. 24, 534\u2013545 (2024).","journal-title":"Curr. Cancer Drug Targets"},{"key":"5008_CR14","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3390\/ijms241310944","volume":"24","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Autophagy regulators in cancer. Int. J. Mol. Sci. 24, 10944 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"5008_CR15","doi-asserted-by":"crossref","unstructured":"Anitha, K. et al. In role of autophagy and reactive oxygen species in cancer treatment: principles and current strategies 73\u201393 (Springer, 2024).","DOI":"10.1007\/978-3-031-66421-2_4"},{"key":"5008_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.gendis.2021.10.010","volume":"10","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. The role of autophagy in regulating metabolism in the tumor microenvironment. Genes Dis. 10, 447\u2013456 (2023).","journal-title":"Genes Dis."},{"key":"5008_CR17","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.3390\/ijms25137459","volume":"25","author":"AMIA Hassan","year":"2024","unstructured":"Hassan, A. M. I. A., Zhao, Y., Chen, X. & He, C. Blockage of autophagy for cancer therapy: A comprehensive review. Int. J. Mol. Sci. 25, 7459 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"5008_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2022.153","volume":"31","author":"MJ Lee","year":"2023","unstructured":"Lee, M. J., Park, J. S., Jo, S. B. & Joe, Y. A. Enhancing anti-cancer therapy with selective autophagy inhibitors by targeting protective autophagy. Biomol. Ther. 31, 1 (2023).","journal-title":"Biomolecules Ther."},{"key":"5008_CR19","unstructured":"Chen, F. et al. The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy. Cancer Metastasis Rev., 1\u201325 (2024)."},{"key":"5008_CR20","doi-asserted-by":"publisher","first-page":"1243613","DOI":"10.3389\/fphar.2023.1243613","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. The mechanisms of action of mitochondrial targeting agents in cancer: Inhibiting oxidative phosphorylation and inducing apoptosis. Front. Pharmacol. 14, 1243613 (2023).","journal-title":"Front. Pharmacol."},{"key":"5008_CR21","doi-asserted-by":"publisher","first-page":"10420","DOI":"10.3390\/ijms241310420","volume":"24","author":"C Musicco","year":"2023","unstructured":"Musicco, C., Signorile, A., Pesce, V., Loguercio Polosa, P. & Cormio, A. Mitochondria deregulations in cancer offer several potential targets of therapeutic interventions. Int. J. Mol. Sci. 24, 10420 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"5008_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","volume":"39","author":"H Wang","year":"2018","unstructured":"Wang, H., Mu, X., He, H. & Zhang, X. D. Cancer radiosensitizers. Trends Pharmacol. Sci. 39, 24\u201348 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"5008_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/09553002.2014.946111","volume":"91","author":"L Barazzuol","year":"2015","unstructured":"Barazzuol, L. et al. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays. Int. J. Radiat. Biol. 91, 90\u201398 (2015).","journal-title":"Int. J. Radiat. Biol."},{"key":"5008_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/09553002.2017.1231946","volume":"93","author":"C Rae","year":"2017","unstructured":"Rae, C. & Mairs, R. J. Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells. Int. J. Radiat. Biol. 93, 194\u2013203 (2017).","journal-title":"Int. J. Radiat. Biol."},{"key":"5008_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jcpt.12410","volume":"41","author":"L Ge","year":"2016","unstructured":"Ge, L. et al. Network meta-analysis of Chinese herb injections combined with FOLFOX chemotherapy in the treatment of advanced colorectal cancer. J. Clin. Pharm. Ther. 41, 383\u2013391 (2016).","journal-title":"J. Clin. Pharm. Ther."},{"key":"5008_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3857\/roj.2018.00381","volume":"36","author":"V Kuruba","year":"2018","unstructured":"Kuruba, V. & Gollapalli, P. Natural radioprotectors and their impact on cancer drug discovery. Radiat. Oncol. J. 36, 265 (2018).","journal-title":"Radiation Oncol. J."},{"key":"5008_CR27","first-page":"885","volume":"12","author":"P Gao","year":"2019","unstructured":"Gao, P., Hao, F., Dong, X. & Qiu, Y. The role of autophagy and Beclin-1 in radiotherapy-induced apoptosis in thyroid carcinoma cells. Int. J. Clin. Exp. Pathol. 12, 885 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"5008_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01178-6","volume":"19","author":"M Jiang","year":"2020","unstructured":"Jiang, M. et al. Dying tumor cell-derived Exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer. Mol. Cancer. 19, 1\u201315 (2020).","journal-title":"Mol. Cancer"},{"key":"5008_CR29","doi-asserted-by":"publisher","first-page":"096032712311808","DOI":"10.1177\/09603271231180849","volume":"42","author":"RE Maarouf","year":"2023","unstructured":"Maarouf, R. E., Azab, K. S., Fatih, E., Helal, N. M., Rashed, L. & H. & Withania somnifera alter BCL2\/Bax signaling and trigger apoptosis of MCF-7 and MDA-MB231 breast cancer cells exposed to \u03b3-radiation. Hum. Exp. Toxicol. 42, 09603271231180849 (2023).","journal-title":"Hum. Exp. Toxicol."},{"key":"5008_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"X Li","year":"2020","unstructured":"Li, X., He, S. & Ma, B. Autophagy and autophagy-related proteins in cancer. Mol. Cancer. 19, 1\u201316 (2020).","journal-title":"Mol. Cancer"},{"key":"5008_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00456-6","volume":"10","author":"D Xia","year":"2020","unstructured":"Xia, D. et al. Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKII\u03b1-associated activation of autophagy. Cell. Biosci. 10, 1\u201312 (2020).","journal-title":"Cell. Bioscience"},{"key":"5008_CR32","doi-asserted-by":"crossref","unstructured":"Gao, L., Zheng, H., Cai, Q. & Wei, L. in Autophagy: Biology and Diseases 375\u2013387 (Springer, 2020).","DOI":"10.1007\/978-981-15-4272-5_25"},{"key":"5008_CR33","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.3390\/ijms24076019","volume":"24","author":"H Bashiri","year":"2023","unstructured":"Bashiri, H. & Tabatabaeian, H. Autophagy: A potential therapeutic target to tackle drug resistance in multiple myeloma. Int. J. Mol. Sci. 24, 6019 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"5008_CR34","doi-asserted-by":"crossref","unstructured":"Qin, Y. et al. Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence. Cancer Lett.  216307 (2023).","DOI":"10.1016\/j.canlet.2023.216307"},{"key":"5008_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/carcin\/bgz015","volume":"40","author":"N Muniraj","year":"2019","unstructured":"Muniraj, N. et al. Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells. Carcinogenesis 40, 1110\u20131120 (2019).","journal-title":"Carcinogenesis"},{"key":"5008_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","volume":"55","author":"TT Nguyen","year":"2023","unstructured":"Nguyen, T. T. et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp. Mol. Med. 55, 1595\u20131619 (2023).","journal-title":"Exp. Mol. Med."},{"key":"5008_CR37","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.3390\/ijms25137305","volume":"25","author":"E Marzetti","year":"2024","unstructured":"Marzetti, E., Calvani, R., Landi, F., Coelho-J\u00fanior, H. J. & Picca, A. Mitochondrial quality control processes at the crossroads of cell death and survival: Mechanisms and signaling pathways. Int. J. Mol. Sci. 25, 7305 (2024).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05008-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:29:25Z","timestamp":1749054565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05008-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05008-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were carried out in compliance with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and were approved by the Institutional Animal Care and Use Committee (IACUC) of Tianjin Institute of Radiation Medicine (TIRM-IACUC-2022-0032).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"19695"}}